首页> 外文期刊>Journal of biopharmaceutical statistics >Commentary on “Accounting for the Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial”
【24h】

Commentary on “Accounting for the Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial”

机译:Commentary on “Accounting for the Interim Safety Monitoring of an Adverse Event Upon Termination of a Clinical Trial”

获取原文
获取原文并翻译 | 示例
       

摘要

After more than 100 deaths caused by the Elixir Sulfanilamide disaster,in 1938,the U.S.Congress passed the Federal Food,Drug,and Cosmetic Act(FDC Act) which for the first time in U.S.history required pharmaceutical companies to submit full reports of investigations regarding the safety of new drugs.

著录项

  • 来源
    《Journal of biopharmaceutical statistics》 |2008年第4期|641-643|共3页
  • 作者

    Jen-pei Liu;

  • 作者单位

    Department of Agronomy, Division of Biometry, National Taiwan University, Taipei, Taiwan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 药学;
  • 关键词

  • 入库时间 2024-01-25 19:33:14
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号